Staar Surgical (STAA) Common Equity (2010 - 2026)

Staar Surgical has reported Common Equity for 17 years, with the latest figure at $352.4 million in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 0.68% year-over-year to $352.4 million; the trailing twelve-month figure through Apr 2026 stood at $352.4 million (up 0.68% YoY), and the FY2026 full-year result was $344.2 million, down 13.38% from the prior year.
• Common Equity for Q2 2026 stood at $352.4 million, up from $344.2 million in the prior quarter.
• The five-year high for Common Equity was $428.1 million in Q3 2024, with the low at $276.3 million in Q2 2022.
• Historically, Common Equity has averaged $356.9 million across 5 years, with a median of $352.4 million in 2026.
• Annual changes were most pronounced in 2022 — Common Equity increased 29.72% — and 2025, when it declined 17.73%.
• Staar Surgical's Common Equity stood at $336.1 million in 2022, then gained by 14.83% to $386.0 million in 2023, then gained by 2.95% to $397.3 million in 2024, then decreased by 10.96% to $353.8 million in 2025, then dropped by 0.4% to $352.4 million in 2026.
• The last three Common Equity figures came in at $352.4 million (Q2 2026), $344.2 million (Q1 2026), and $353.8 million (Q3 2025), per Business Quant data.